Pain Relief Medication Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Drug Class (Nonsteroidal Anti-Inflammatory Drugs, Opioids, Others); Indication (Cancer Pain, Neuropathic Pain, Musculoskeletal Pain, Others); Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies)
Report Code: TIPRE00011963 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Pain relievers are medicines that relieve headaches, sore muscles, arthritis, or other aches and pains. There are many different pain medicines, and each one has advantages and risks. Some types of pain respond better to certain medications than others. Medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy is an essential part of the medical field and relies on the science of pharmacology for continual advancement and pharmacy for appropriate management.
MARKET DYNAMICS
The pain relief medication market is driving due to the increasing expenditure capacity of the normal human beings, better inclusion in hospitals and various treatments. Moreover, hike in research funding, better drug development technology using AI and other advanced technologies, hike in clearance rate, government support boosts the growth of the market for pain relief medication.
MARKET SCOPE
The "Pain Relief Medication Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pain relief medication market with detailed market segmentation by drug class, indication and distribution channel. The pain relief medication market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pain relief medication market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pain relief medication market is segmented on the basis of drug class, indication and distribution channel. Based on drug class, the market is segmented as nonsteroidal anti-inflammatory drugs, opioids and others. On the basis of indication, the market is categorized as cancer pain, neuropathic pain, musculoskeletal pain and others. On the basis of distribution channel, the market is categorized as hospital and retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pain relief medication market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pain relief medication market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pain relief medication market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pain relief medication market in these regions.
The report covers key developments in the pain relief medication market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pain relief medication market are anticipated to have lucrative growth opportunities in the future with the rising demand for pain relief medication in the global market. Below mentioned is the list of few companies engaged in the pain relief medication market.
The report also includes the profiles of key players in pain relief medication market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Pain relievers are medicines that relieve headaches, sore muscles, arthritis, or other aches and pains. There are many different pain medicines, and each one has advantages and risks. Some types of pain respond better to certain medications than others. Medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy is an essential part of the medical field and relies on the science of pharmacology for continual advancement and pharmacy for appropriate management.
MARKET DYNAMICS
The pain relief medication market is driving due to the increasing expenditure capacity of the normal human beings, better inclusion in hospitals and various treatments. Moreover, hike in research funding, better drug development technology using AI and other advanced technologies, hike in clearance rate, government support boosts the growth of the market for pain relief medication.
MARKET SCOPE
The "Pain Relief Medication Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pain relief medication market with detailed market segmentation by drug class, indication and distribution channel. The pain relief medication market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pain relief medication market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pain relief medication market is segmented on the basis of drug class, indication and distribution channel. Based on drug class, the market is segmented as nonsteroidal anti-inflammatory drugs, opioids and others. On the basis of indication, the market is categorized as cancer pain, neuropathic pain, musculoskeletal pain and others. On the basis of distribution channel, the market is categorized as hospital and retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pain relief medication market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pain relief medication market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pain relief medication market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pain relief medication market in these regions.
The report covers key developments in the pain relief medication market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pain relief medication market are anticipated to have lucrative growth opportunities in the future with the rising demand for pain relief medication in the global market. Below mentioned is the list of few companies engaged in the pain relief medication market.
The report also includes the profiles of key players in pain relief medication market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AbbVie Inc. (US)
- Allergan PLC (Ireland)
- Astellas Pharma Inc. (Japan)
- Bayer (Germany)
- Biogen Idec (US)
- Boehringer Ingelheim International GmbH (Germany)
- Bristol-Myers Squibb (US)
- Eli Lilly and Company (US)
- GlaxoSmithKline (UK)
- Mallinckrodt Pharmaceuticals (UK)
- Pfizer, Inc. (US)
- Purdue Pharma (US)
- Sanofi (France)
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pain Relief Medication Market - By Drug Class
1.3.2 Pain Relief Medication Market - By Indication
1.3.3 Pain Relief Medication Market - By Distribution Channel
1.3.4 Pain Relief Medication Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PAIN RELIEF MEDICATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PAIN RELIEF MEDICATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PAIN RELIEF MEDICATION MARKET - GLOBAL MARKET ANALYSIS
6.1. PAIN RELIEF MEDICATION - GLOBAL MARKET OVERVIEW
6.2. PAIN RELIEF MEDICATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.1. Overview
7.3.2. Nonsteroidal Anti-Inflammatory Drugs Market Forecast and Analysis
7.4. OPIOIDS
7.4.1. Overview
7.4.2. Opioids Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER PAIN
8.3.1. Overview
8.3.2. Cancer Pain Market Forecast and Analysis
8.4. NEUROPATHIC PAIN
8.4.1. Overview
8.4.2. Neuropathic Pain Market Forecast and Analysis
8.5. MUSCULOSKELETAL PAIN
8.5.1. Overview
8.5.2. Musculoskeletal Pain Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL AND RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
10. PAIN RELIEF MEDICATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pain Relief Medication Market Overview
10.1.2 North America Pain Relief Medication Market Forecasts and Analysis
10.1.3 North America Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.1.4 North America Pain Relief Medication Market Forecasts and Analysis - By Indication
10.1.5 North America Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pain Relief Medication Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pain Relief Medication Market
10.1.6.1.1 United States Pain Relief Medication Market by Drug Class
10.1.6.1.2 United States Pain Relief Medication Market by Indication
10.1.6.1.3 United States Pain Relief Medication Market by Distribution Channel
10.1.6.2 Canada Pain Relief Medication Market
10.1.6.2.1 Canada Pain Relief Medication Market by Drug Class
10.1.6.2.2 Canada Pain Relief Medication Market by Indication
10.1.6.2.3 Canada Pain Relief Medication Market by Distribution Channel
10.1.6.3 Mexico Pain Relief Medication Market
10.1.6.3.1 Mexico Pain Relief Medication Market by Drug Class
10.1.6.3.2 Mexico Pain Relief Medication Market by Indication
10.1.6.3.3 Mexico Pain Relief Medication Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pain Relief Medication Market Overview
10.2.2 Europe Pain Relief Medication Market Forecasts and Analysis
10.2.3 Europe Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Pain Relief Medication Market Forecasts and Analysis - By Indication
10.2.5 Europe Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pain Relief Medication Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pain Relief Medication Market
10.2.6.1.1 Germany Pain Relief Medication Market by Drug Class
10.2.6.1.2 Germany Pain Relief Medication Market by Indication
10.2.6.1.3 Germany Pain Relief Medication Market by Distribution Channel
10.2.6.2 France Pain Relief Medication Market
10.2.6.2.1 France Pain Relief Medication Market by Drug Class
10.2.6.2.2 France Pain Relief Medication Market by Indication
10.2.6.2.3 France Pain Relief Medication Market by Distribution Channel
10.2.6.3 Italy Pain Relief Medication Market
10.2.6.3.1 Italy Pain Relief Medication Market by Drug Class
10.2.6.3.2 Italy Pain Relief Medication Market by Indication
10.2.6.3.3 Italy Pain Relief Medication Market by Distribution Channel
10.2.6.4 Spain Pain Relief Medication Market
10.2.6.4.1 Spain Pain Relief Medication Market by Drug Class
10.2.6.4.2 Spain Pain Relief Medication Market by Indication
10.2.6.4.3 Spain Pain Relief Medication Market by Distribution Channel
10.2.6.5 United Kingdom Pain Relief Medication Market
10.2.6.5.1 United Kingdom Pain Relief Medication Market by Drug Class
10.2.6.5.2 United Kingdom Pain Relief Medication Market by Indication
10.2.6.5.3 United Kingdom Pain Relief Medication Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pain Relief Medication Market Overview
10.3.2 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis
10.3.3 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pain Relief Medication Market
10.3.6.1.1 Australia Pain Relief Medication Market by Drug Class
10.3.6.1.2 Australia Pain Relief Medication Market by Indication
10.3.6.1.3 Australia Pain Relief Medication Market by Distribution Channel
10.3.6.2 China Pain Relief Medication Market
10.3.6.2.1 China Pain Relief Medication Market by Drug Class
10.3.6.2.2 China Pain Relief Medication Market by Indication
10.3.6.2.3 China Pain Relief Medication Market by Distribution Channel
10.3.6.3 India Pain Relief Medication Market
10.3.6.3.1 India Pain Relief Medication Market by Drug Class
10.3.6.3.2 India Pain Relief Medication Market by Indication
10.3.6.3.3 India Pain Relief Medication Market by Distribution Channel
10.3.6.4 Japan Pain Relief Medication Market
10.3.6.4.1 Japan Pain Relief Medication Market by Drug Class
10.3.6.4.2 Japan Pain Relief Medication Market by Indication
10.3.6.4.3 Japan Pain Relief Medication Market by Distribution Channel
10.3.6.5 South Korea Pain Relief Medication Market
10.3.6.5.1 South Korea Pain Relief Medication Market by Drug Class
10.3.6.5.2 South Korea Pain Relief Medication Market by Indication
10.3.6.5.3 South Korea Pain Relief Medication Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pain Relief Medication Market Overview
10.4.2 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis
10.4.3 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pain Relief Medication Market
10.4.6.1.1 South Africa Pain Relief Medication Market by Drug Class
10.4.6.1.2 South Africa Pain Relief Medication Market by Indication
10.4.6.1.3 South Africa Pain Relief Medication Market by Distribution Channel
10.4.6.2 Saudi Arabia Pain Relief Medication Market
10.4.6.2.1 Saudi Arabia Pain Relief Medication Market by Drug Class
10.4.6.2.2 Saudi Arabia Pain Relief Medication Market by Indication
10.4.6.2.3 Saudi Arabia Pain Relief Medication Market by Distribution Channel
10.4.6.3 U.A.E Pain Relief Medication Market
10.4.6.3.1 U.A.E Pain Relief Medication Market by Drug Class
10.4.6.3.2 U.A.E Pain Relief Medication Market by Indication
10.4.6.3.3 U.A.E Pain Relief Medication Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pain Relief Medication Market Overview
10.5.2 South and Central America Pain Relief Medication Market Forecasts and Analysis
10.5.3 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pain Relief Medication Market
10.5.6.1.1 Brazil Pain Relief Medication Market by Drug Class
10.5.6.1.2 Brazil Pain Relief Medication Market by Indication
10.5.6.1.3 Brazil Pain Relief Medication Market by Distribution Channel
10.5.6.2 Argentina Pain Relief Medication Market
10.5.6.2.1 Argentina Pain Relief Medication Market by Drug Class
10.5.6.2.2 Argentina Pain Relief Medication Market by Indication
10.5.6.2.3 Argentina Pain Relief Medication Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PAIN RELIEF MEDICATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PAIN RELIEF MEDICATION MARKET, KEY COMPANY PROFILES
13.1. ABBVIE INC. (US)
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALLERGAN PLC (IRELAND)
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTELLAS PHARMA INC. (JAPAN)
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BAYER (GERMANY)
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOGEN IDEC (US)
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BOEHRINGER INGELHEIM INTERNATIONAL GMBH (GERMANY)
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BRISTOL-MYERS SQUIBB (US)
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ELI LILLY AND COMPANY (US)
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GLAXOSMITHKLINE (UK)
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MALLINCKRODT PHARMACEUTICALS (UK)
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. PFIZER, INC. (US)
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
13.12. PURDUE PHARMA (US)
13.12.1. Key Facts
13.12.2. Business Description
13.12.3. Products and Services
13.12.4. Financial Overview
13.12.5. SWOT Analysis
13.12.6. Key Developments
13.13. SANOFI (FRANCE)
13.13.1. Key Facts
13.13.2. Business Description
13.13.3. Products and Services
13.13.4. Financial Overview
13.13.5. SWOT Analysis
13.13.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pain Relief Medication Market - By Drug Class
1.3.2 Pain Relief Medication Market - By Indication
1.3.3 Pain Relief Medication Market - By Distribution Channel
1.3.4 Pain Relief Medication Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PAIN RELIEF MEDICATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PAIN RELIEF MEDICATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PAIN RELIEF MEDICATION MARKET - GLOBAL MARKET ANALYSIS
6.1. PAIN RELIEF MEDICATION - GLOBAL MARKET OVERVIEW
6.2. PAIN RELIEF MEDICATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.1. Overview
7.3.2. Nonsteroidal Anti-Inflammatory Drugs Market Forecast and Analysis
7.4. OPIOIDS
7.4.1. Overview
7.4.2. Opioids Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER PAIN
8.3.1. Overview
8.3.2. Cancer Pain Market Forecast and Analysis
8.4. NEUROPATHIC PAIN
8.4.1. Overview
8.4.2. Neuropathic Pain Market Forecast and Analysis
8.5. MUSCULOSKELETAL PAIN
8.5.1. Overview
8.5.2. Musculoskeletal Pain Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL AND RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
10. PAIN RELIEF MEDICATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pain Relief Medication Market Overview
10.1.2 North America Pain Relief Medication Market Forecasts and Analysis
10.1.3 North America Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.1.4 North America Pain Relief Medication Market Forecasts and Analysis - By Indication
10.1.5 North America Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pain Relief Medication Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pain Relief Medication Market
10.1.6.1.1 United States Pain Relief Medication Market by Drug Class
10.1.6.1.2 United States Pain Relief Medication Market by Indication
10.1.6.1.3 United States Pain Relief Medication Market by Distribution Channel
10.1.6.2 Canada Pain Relief Medication Market
10.1.6.2.1 Canada Pain Relief Medication Market by Drug Class
10.1.6.2.2 Canada Pain Relief Medication Market by Indication
10.1.6.2.3 Canada Pain Relief Medication Market by Distribution Channel
10.1.6.3 Mexico Pain Relief Medication Market
10.1.6.3.1 Mexico Pain Relief Medication Market by Drug Class
10.1.6.3.2 Mexico Pain Relief Medication Market by Indication
10.1.6.3.3 Mexico Pain Relief Medication Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pain Relief Medication Market Overview
10.2.2 Europe Pain Relief Medication Market Forecasts and Analysis
10.2.3 Europe Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Pain Relief Medication Market Forecasts and Analysis - By Indication
10.2.5 Europe Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pain Relief Medication Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pain Relief Medication Market
10.2.6.1.1 Germany Pain Relief Medication Market by Drug Class
10.2.6.1.2 Germany Pain Relief Medication Market by Indication
10.2.6.1.3 Germany Pain Relief Medication Market by Distribution Channel
10.2.6.2 France Pain Relief Medication Market
10.2.6.2.1 France Pain Relief Medication Market by Drug Class
10.2.6.2.2 France Pain Relief Medication Market by Indication
10.2.6.2.3 France Pain Relief Medication Market by Distribution Channel
10.2.6.3 Italy Pain Relief Medication Market
10.2.6.3.1 Italy Pain Relief Medication Market by Drug Class
10.2.6.3.2 Italy Pain Relief Medication Market by Indication
10.2.6.3.3 Italy Pain Relief Medication Market by Distribution Channel
10.2.6.4 Spain Pain Relief Medication Market
10.2.6.4.1 Spain Pain Relief Medication Market by Drug Class
10.2.6.4.2 Spain Pain Relief Medication Market by Indication
10.2.6.4.3 Spain Pain Relief Medication Market by Distribution Channel
10.2.6.5 United Kingdom Pain Relief Medication Market
10.2.6.5.1 United Kingdom Pain Relief Medication Market by Drug Class
10.2.6.5.2 United Kingdom Pain Relief Medication Market by Indication
10.2.6.5.3 United Kingdom Pain Relief Medication Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pain Relief Medication Market Overview
10.3.2 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis
10.3.3 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pain Relief Medication Market
10.3.6.1.1 Australia Pain Relief Medication Market by Drug Class
10.3.6.1.2 Australia Pain Relief Medication Market by Indication
10.3.6.1.3 Australia Pain Relief Medication Market by Distribution Channel
10.3.6.2 China Pain Relief Medication Market
10.3.6.2.1 China Pain Relief Medication Market by Drug Class
10.3.6.2.2 China Pain Relief Medication Market by Indication
10.3.6.2.3 China Pain Relief Medication Market by Distribution Channel
10.3.6.3 India Pain Relief Medication Market
10.3.6.3.1 India Pain Relief Medication Market by Drug Class
10.3.6.3.2 India Pain Relief Medication Market by Indication
10.3.6.3.3 India Pain Relief Medication Market by Distribution Channel
10.3.6.4 Japan Pain Relief Medication Market
10.3.6.4.1 Japan Pain Relief Medication Market by Drug Class
10.3.6.4.2 Japan Pain Relief Medication Market by Indication
10.3.6.4.3 Japan Pain Relief Medication Market by Distribution Channel
10.3.6.5 South Korea Pain Relief Medication Market
10.3.6.5.1 South Korea Pain Relief Medication Market by Drug Class
10.3.6.5.2 South Korea Pain Relief Medication Market by Indication
10.3.6.5.3 South Korea Pain Relief Medication Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pain Relief Medication Market Overview
10.4.2 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis
10.4.3 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pain Relief Medication Market
10.4.6.1.1 South Africa Pain Relief Medication Market by Drug Class
10.4.6.1.2 South Africa Pain Relief Medication Market by Indication
10.4.6.1.3 South Africa Pain Relief Medication Market by Distribution Channel
10.4.6.2 Saudi Arabia Pain Relief Medication Market
10.4.6.2.1 Saudi Arabia Pain Relief Medication Market by Drug Class
10.4.6.2.2 Saudi Arabia Pain Relief Medication Market by Indication
10.4.6.2.3 Saudi Arabia Pain Relief Medication Market by Distribution Channel
10.4.6.3 U.A.E Pain Relief Medication Market
10.4.6.3.1 U.A.E Pain Relief Medication Market by Drug Class
10.4.6.3.2 U.A.E Pain Relief Medication Market by Indication
10.4.6.3.3 U.A.E Pain Relief Medication Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pain Relief Medication Market Overview
10.5.2 South and Central America Pain Relief Medication Market Forecasts and Analysis
10.5.3 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pain Relief Medication Market
10.5.6.1.1 Brazil Pain Relief Medication Market by Drug Class
10.5.6.1.2 Brazil Pain Relief Medication Market by Indication
10.5.6.1.3 Brazil Pain Relief Medication Market by Distribution Channel
10.5.6.2 Argentina Pain Relief Medication Market
10.5.6.2.1 Argentina Pain Relief Medication Market by Drug Class
10.5.6.2.2 Argentina Pain Relief Medication Market by Indication
10.5.6.2.3 Argentina Pain Relief Medication Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PAIN RELIEF MEDICATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PAIN RELIEF MEDICATION MARKET, KEY COMPANY PROFILES
13.1. ABBVIE INC. (US)
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALLERGAN PLC (IRELAND)
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTELLAS PHARMA INC. (JAPAN)
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BAYER (GERMANY)
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOGEN IDEC (US)
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BOEHRINGER INGELHEIM INTERNATIONAL GMBH (GERMANY)
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BRISTOL-MYERS SQUIBB (US)
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ELI LILLY AND COMPANY (US)
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GLAXOSMITHKLINE (UK)
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MALLINCKRODT PHARMACEUTICALS (UK)
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. PFIZER, INC. (US)
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
13.12. PURDUE PHARMA (US)
13.12.1. Key Facts
13.12.2. Business Description
13.12.3. Products and Services
13.12.4. Financial Overview
13.12.5. SWOT Analysis
13.12.6. Key Developments
13.13. SANOFI (FRANCE)
13.13.1. Key Facts
13.13.2. Business Description
13.13.3. Products and Services
13.13.4. Financial Overview
13.13.5. SWOT Analysis
13.13.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. AbbVie Inc. (US)
2. Allergan PLC (Ireland)
3. Astellas Pharma Inc. (Japan)
4. Bayer (Germany)
5. Biogen Idec (US)
6. Boehringer Ingelheim International GmbH (Germany)
7. Bristol-Myers Squibb (US)
8. Eli Lilly and Company (US)
9. GlaxoSmithKline (UK)
10. Mallinckrodt Pharmaceuticals (UK)
11. Pfizer, Inc. (US)
12. Purdue Pharma (US)
13. Sanofi (France)
1. AbbVie Inc. (US)
2. Allergan PLC (Ireland)
3. Astellas Pharma Inc. (Japan)
4. Bayer (Germany)
5. Biogen Idec (US)
6. Boehringer Ingelheim International GmbH (Germany)
7. Bristol-Myers Squibb (US)
8. Eli Lilly and Company (US)
9. GlaxoSmithKline (UK)
10. Mallinckrodt Pharmaceuticals (UK)
11. Pfizer, Inc. (US)
12. Purdue Pharma (US)
13. Sanofi (France)
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
GET FREE SAMPLE PDF
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount